Cognizant (NASDAQ: CTSH) today announced it has acquired Cadient Group, a full-service digital marketing agency that serves a broad spectrum of life sciences companies in the pharmaceutical, biotechnology, consumer health, and medical device industries.
This acquisition further strengthens and expands Cognizant's digital marketing capabilities, enabling brand marketing leaders to transform the way they position their offerings in the digital landscape as they design, develop and introduce multi-channel marketing initiatives, launch brands, build communities, drive insights and analytics, and create a compelling customer experience. The terms of the transaction were not disclosed.
Life sciences companies around the world have significantly increased their emphasis on web, mobile, and social engagement with all of their stakeholders, while increasingly leveraging enterprise-level analytics to drive a customer-centric approach to marketing and sales. Pennsylvania-based Cadient Group has more than a decade of experience in providing digital strategy, marketing, and technology and analytics solutions to industry leaders and emerging companies in the life sciences industry.
As part of this acquisition, more than 100 digital specialists—with expertise across brand strategy and planning, content development, user-centered design, multi-channel analytics, and digital, social and mobile marketing—will join Cognizant. This acquisition also brings to Cognizant digital assets and intellectual property including Reveal, an insights and analytics platform; Immerse, an experiential marketing platform; and OneVoice, an advocacy campaign management platform.
"The life sciences industry is undergoing structural disruption as marketing services enable new digital ways for companies to engage with patients and providers and create compelling user experiences," said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant. "In an increasingly competitive industry with many digitally active stakeholders, the acquisition of Cadient Group will complement Cognizant's digital and interactive solutions capability. It will help brand marketing leaders to innovatively transform their brands, manage customer experience across multiple channels, maintain quality standards and comply with regulations, and achieve greater return on marketing investments. We welcome Cadient's digital specialists to the Cognizant family and are confident that our combined capabilities and digital assets will help both life sciences and broader healthcare companies gain a competitive advantage by managing the information that surrounds organizations, processes, products and people—what we call Code Halos."
"Becoming a part of Cognizant uniquely positions us to deliver integrated solutions to life sciences marketing and sales teams around the world," said Stephen Wray, President and CEO, Cadient Group. "Clients will now have enhanced access to the best creativity and craftsmanship of a design firm combined with the best-in-class management and execution capabilities of a large consulting and technology firm to produce superior customer engagements at the brand and enterprise level. Together, we are ideally positioned to deliver on this promise."
New study aims to reduce bias in AI health prediction models